Significance
In this report, we describe how endothelial cells, the cells lining the interior of blood vessels, invade into tissues to form new vessels through sprouting angiogenesis. We found that endothelial cells use a specific lamellipodia-related membrane protrusion for invasion, which we termed dactylopodia. These protrusions have a special morphology, originate from filopodia, are linked to membrane-ruffling activity, and are specialized in invading into avascular extracellular matrix. Our work lays the foundations for drug discovery targeting sprouting angiogenesis.
Keywords: angiogenesis, endothelial cells, invasion, actin, myosin
Abstract
Sprouting angiogenesis is fundamental for development and contributes to cancer, diabetic retinopathy, and cardiovascular diseases. Sprouting angiogenesis depends on the invasive properties of endothelial tip cells. However, there is very limited knowledge on how tip cells invade into tissues. Here, we show that endothelial tip cells use dactylopodia as the main cellular protrusion for invasion into nonvascular extracellular matrix. We show that dactylopodia and filopodia protrusions are balanced by myosin IIA (NMIIA) and actin-related protein 2/3 (Arp2/3) activity. Endothelial cell-autonomous ablation of NMIIA promotes excessive dactylopodia formation in detriment of filopodia. Conversely, endothelial cell-autonomous ablation of Arp2/3 prevents dactylopodia development and leads to excessive filopodia formation. We further show that NMIIA inhibits Rac1-dependent activation of Arp2/3 by regulating the maturation state of focal adhesions. Our discoveries establish a comprehensive model of how endothelial tip cells regulate its protrusive activity and will pave the way toward strategies to block invasive tip cells during sprouting angiogenesis.
The formation of new blood vessels from preexisting ones—sprouting angiogenesis—is a fundamental process in health and disease (1, 2). Sprouting angiogenesis depends on the ability of a specialized endothelial cell (EC)—the tip cell—to invade and migrate into tissues (3), yet we still lack basic understanding of how endothelial tip cells migrate and invade into tissues. During three-dimensional cell migration, endothelial tip cells, as other mesenchymal-like cells such as fibroblasts and cancer cells, adopt a vast array of polarized membrane protrusions, which are essential for invasion and guidance (4–7). Membrane protrusions, such as lamellipodia and filopodia, are driven by actin dynamics (6, 8). Formin-dependent linear actin arrays promote filopodia formation, while actin-related protein 2/3 (Arp2/3) complex-dependent, dendritic actin arrays promote lamellipodia formation (6). In addition, nonmuscle myosin II (NNMII)-dependent contractility was shown to inhibit protrusions and to promote membrane blebbing, through cortical tension (9, 10), while a recent study showed that NNMIIA, a specific NNMII isoform, could also promote filopodia stability (11). The balance between these different filamentous actin networks and their regulators shapes the types of cellular protrusions formed and hence the mode of migration.
Vascular endothelial growth factor (VEGF) signaling is a master regulator of tip cell biology, and it was shown to regulate endothelial tip cell invasion and sprouting angiogenesis (1, 2, 12). CDC42 and RAC1, downstream of VEGF, are master regulators of endothelial tip cell membrane protrusions (13–15). VEGF also activates serum response factor (SRF), a transcription factor highly expressed by endothelial tip cells. Together with its cofactors myocardin-related transcription factors (MRTFs), SRF regulates endothelial invasive behavior by promoting filopodia formation (16–18). In addition, focal adhesions (FAs) are also crucial for EC migration and invasion, and deletion of integrin-linked kinase or integrin β1 (ITGB1) leads to severe sprouting angiogenesis defects and changes in tip cell protrusive activity (19, 20).
Despite their central role in tip cell invasion, it remains to be determined how actomyosin and its regulators affect cell shape and protrusive behavior and how different membrane protrusions influence EC migration in vivo. For instance, by using low doses of latrunculin B, a pharmacological inhibitor of actin polymerization, a recent report proposed that filopodia are dispensable for EC guidance and migration in zebrafish (21), generating controversy in the field.
Here, we investigated the specialized membrane protrusions on endothelial tip cells and their physiological relevance for EC invasion and angiogenesis in vivo and generated an integrative model of how endothelial tip cells invade into tissues.
Results
SRF/MRTFs activity was shown to regulate NNMII levels in ECs (16). ECs express mostly two isoforms of NNMII, NNMIIA and NNMIIB, which are coded by Myh9 and Myh10, respectively (betsholtzlab.org/VascularSingleCells/database.html) (22). To evaluate the function of NNMII in endothelial tip cells, we first investigated the location and expression levels of NNMIIA and NNMIIB. We first focused on NNMIIA. We found that endothelial tip cells express higher levels of NNMIIA than stalk cells, the cells juxtapose to tip cells that participate in the invading vascular sprout (Fig. 1 A and B, SI Appendix, Fig. S1 A and B, and Movies S1 and S2). We further confirmed these observations by imaging fluorescently tagged NMIIA, using the Myh9-eGFP transgenic animals (SI Appendix, Fig. S2A) (23). In addition to higher expression, we found that NMIIA was enriched at the base of filopodia protrusions (Fig. 1 A and C and SI Appendix, Fig. S2 B and C). NMIIB followed a similar pattern to NMIIA. It is highly expressed by endothelial tip cells, and it is enriched at the base of filopodia (SI Appendix, Fig. S2C). This spatial distribution of NMII isoforms correlates with high levels of phospho-myosin light chain and filamentous actin (SI Appendix, Fig. S2 B–D). These results suggest that endothelial tip cells have higher levels of actomyosin contractility at their leading edges, in particular at the base of filopodia. To evaluate the function of NMIIA and NMIIB in ECs, we deleted Myh9 or Myh10 alone, or both simultaneously, using the PDGFB-CreERT2 line (24). Single deletion of Myh10 in ECs (NMIIB EC knockout [KO]) did not significantly affect retinal vascular morphogenesis, although we noticed a small decrease in the number of filopodia in endothelial tip cells (SI Appendix, Fig. S3 A–C). Efficient depletion of NMIIB was observed by immunofluorescence (SI Appendix, Fig. S3B). Single deletion of Myh9 (NMIIA EC-KO) showed a very distinct phenotype. NMIIA EC-KO retinas showed a mild decrease in radial expansion, an increase in vessel density, decreased proliferation, and an increase in the number of tip cells (Fig. 1 D–F). In accordance with a mild radial expansion phenotype, vascularization of the superficial in NMIIA EC-KO animals reached the retina margin by postnatal day 12 (P12) (SI Appendix, Fig. S4). Yet the most striking phenotype is a dramatic change in tip cell morphology (Fig. 1E and SI Appendix, Fig. S4A). NMIIA-deficient tip cells showed an abnormal branched morphology with extremely long and enlarged membrane protrusions and a severe decrease in filopodia number (Fig. 1E and SI Appendix, Fig. S5A). Remarkably, the absence of filopodia and enlarged membrane protrusions was tip cell specific, as ECs in nonsprouting areas showed numerous bona fide filopodia morphologically similar to wild-type (WT) control littermates, even if NMIIA-deficient ECs in the plexus show a trend to have a decreased number of filopodia (SI Appendix, Fig. S5 B and C). Immunofluorescence analysis confirmed the efficient depletion of NMIIA (Fig. 1G) and that the NMIIA EC-KO phenotype manifested even in the presence of high levels of NMIIB in tip cells (SI Appendix, Fig. S5D). Despite the notable changes in tip cell morphology, filamentous actin did not appear to be severely compromised with noticeable actin cables present in the cell cortex (Fig. 1G). Abrogation of both Myh9 and Myh10 led to an extremely severe phenotype, in which ECs at the sprouting front lacked filopodia and showed very elongated and slim membrane protrusions, likely caused by a complete disruption of actomyosin contractility (SI Appendix, Fig. S6 A–C). Altogether, these results revealed that NMIIA plays a fundamental role in the formation of tip cells’ filopodia, which cannot be rescued by NMIIB. In addition, NMIIA and NMIIB, together, are essential to maintain EC shape. This is consistent with previous observations that both NMII isoforms play overlapping but also unique roles (23, 25–27).
The specific impairment of filopodia formation and the presence of long membrane protrusions in NMIIA-deficient tip cells, suggested that NMIIA plays an important role in the regulation on the type of membrane protrusions that tip cells produce (Fig. 1 E and G and SI Appendix, Fig. S5A). Thus, we decided to investigate the dynamics of membrane protrusions in endothelial tip cells in vivo. To do so, we established a protocol for live imaging of the mouse retina. Briefly, intact retinas are flat mounted using low-melting agarose and imaged shortly after retinal dissection on a multiphoton microscope (details in Methods). This protocol differs from previous protocols (28, 29), as it uses low-melting agarose which maintains retinal structure in a flat-mounted state that enables long-term (up to 6 h), high-resolution imaging using immersion objectives. Live imaging showed that WT endothelial tip cells have a high rate of filopodia formation (∼0.6 filopodia/s) (Fig. 2 A and B, SI Appendix, Fig. S7 A and B, and Movies S3–S6). Surprisingly, live imaging of NMIIA-deficient retinas showed that tip cells were also able to protrude filopodia, albeit with significant altered dynamics (lower rate of initiation, lower extension speed, and duration of extension) (Fig. 2 A and B, SI Appendix, Fig. S7 A and B, and Movies S7–S11). Intriguingly, in both NMIIA WT and NMIIA EC-KO tip cells, we observed an unexpected membrane-ruffling activity at the filopodia membrane (Fig. 2 A and B, SI Appendix, Fig. S7 A and B, and Movies S7–S11). WT tip cells exhibited membrane ruffling both at filopodium’s base and along filopodium’s lateral membrane (Fig. 2 A and B and Movies S3–S6), yet ruffling activity was not a general feature of all filopodia. In our imaging conditions, only a small proportion of filopodia showed ruffling activity in their lifespan, and most of them extended and retracted without detectable ruffling activity. Moreover, when present, filopodium’s ruffling was normally short lived (1 to 6 min). Ruffling activity at filopodium’s base was associated with extension and enlargement of the cytoplasmic membrane (Fig. 2 A and B and SI Appendix, Fig. S7 A and B). Live imaging of NMIIA WT LifeAct-GFP retinas showed high and dynamic actin polymerization at the base of filopodia (SI Appendix, Fig. S7C and Movies S12 and S13), suggesting that membrane ruffling is driven by actin polymerization. In contrast to NMIIA WT tip cells, membrane ruffling in NMIIA EC-KO tip cells was more persistent and generally led to the conversion of filopodia into long membrane protrusions, similar to the ones observed in fixed samples (Fig. 2A, SI Appendix, Fig. S7A, and Movies S7–S11). Thus, our live-imaging observations indicate that long membrane protrusions in NMIIA-deficient tip cells are originated from altered filopodia dynamics through excessive actin-dependent membrane ruffling. Moreover, they suggest that one key function of NMIIA in tip cells is to negatively regulate the formation of such long protrusions.
Given that NMIIA WT tip cells also showed substantial filopodia membrane ruffling (Movies S4–S6), we reasoned that the formation of long membrane protrusions might be a particular feature of WT tip cells that become overrepresented in NMIIA EC-KO. Indeed, careful analysis of WT tip cells showed similar morphological membrane protrusions, comparable to the prominent ones observed in NMIIA EC-KO tip cells, yet their frequency and size were much reduced (Fig. 2 C–E and SI Appendix, Fig. S8A). In WT tip cells, these membrane protrusions were characterized by a mean length of ∼20 µm (ranging from ∼5 to ∼33 µm) and a mean width of ∼2 µm (ranging from ∼0.7 to ∼5 µm) (Fig. 2E), enriched in actin and NMIIA, and from which numerous filopodia emanated (Fig. 2 C and D and SI Appendix, Fig. S8B). Given their morphology (finger-like protrusions), originated from filopodia and linked to membrane-ruffling activity, we named these naturally occurring protrusions as dactylopodia. Interestingly, the presence of dactylopodia correlated with regions where endothelial tip cells contacted with nonvascular extracellular matrices (ECM), highlighted by decreased staining of the vascular basement membrane marker collagen IV (Fig. 2F and SI Appendix, Fig. S8C). Moreover, dactylopodia were associated with increased levels of active ITGB1, a marker for matrix-bound FAs (SI Appendix, Fig. S8C). Dactylopodia in NMIIA-deficient ECs also correlated with sites of contact with nonvascular extracellular matrix and with activated ITGB1; however, its expression pattern appeared to be more diffused along dactylopodia and not enriched at the base of filopodia, as in WT cells (SI Appendix, Fig. S8C). Altogether, these data suggest that dactylopodia are endothelial tip cell–specific protrusions derived from filopodia that might play roles in invasion and migration into nonvascular ECM.
Next, we investigated the mechanism driving dactylopodia formation in ECs. Actin-based membrane ruffling is known to rely on Arp2/3-dependent, dendritic actin networks (6). To confirm if Arp2/3 is involved in dactylopodia formation, we specifically deleted Arpc4, a structurally essential component of the Arp2/3 complex (5, 30), in ECs in vivo. Deletion of Arpc4 in ECs, Arpc4 EC-KO, led to a very prominent vascular phenotype. ECs without a functional Arp2/3 complex were unable to invade into avascular areas, leading to a dramatic reduction in radial expansion at P6 (Fig. 3 A–C). Higher magnification of tip cells demonstrated that Arpc4-deficient cells had a reduced number of dactylopodia, which correlated with an increase in the number and length of filopodia (Fig. 3 B, D, and E). Strikingly, Arpc4 EC-KO phenotype inversely mirrors NMIIA EC-KO phenotype in terms of tip cells’ filopodia and dactylopodia number and morphology (compare Figs. 1 E and F and 3 B and C). Yet Arp2/3 deficiency did not alter NMIIA distribution in endothelial tip cells (Fig. 3D). Analysis of P12 retinas showed that radial expansion was completely abrogated, as radial outgrowth was mostly at the same distance from the optic nerve as in P6 retinas (SI Appendix, Fig. S9A). Altogether, we conclude that dactylopodia are formed by Arp2/3-dependent actin polymerization and that endothelial tip cell invasiveness is entirely determined by Arp2/3 activity. Moreover, it proves that the presence of filopodia is insufficient for tip cell invasion.
Next, we investigated how the balance between filopodia and dactylopodia in endothelial tip cells is established. Remarkably, NMIIA KO phenotype was characterized by a loss of filopodia and a gain in dactylopodia, while Arpc4 EC-KO displayed excessive filopodia and a reduced number of dactylopodia. Moreover, we showed that dactylopodia originated from filopodia. Thus, we hypothesized that NMIIA could balance the ability of tip cells to form filopodia over dactylopodia by regulating Arp2/3 complex activity. A prediction from this model is that inhibition of the Arp2/3 complex in NMIIA-deficient cells should rescue the ability of ECs to produce filopodia. To test this hypothesis, we turned to in vitro human umbilical vein EC (HUVEC) cultures. ECs’ growth on glass or plastic did not show the ability to form long filopodia. However, when seeded on top of fibroblast monolayers, HUVECs acquired this capacity (31). However, in both in vitro conditions, HUVECs did not display protrusions similar to dactylopodia but rather standard lamellipodia. DMSO-treated or CK666-treated (a specific inhibitor of Arp2/3) cells have a similar number of filopodia in normal conditions. In contrast, blebbistatin (BBS), an inhibitor of NMII activity, abrogated filopodia formation. Remarkably, filopodia formation in BBS-treated cells was partially rescued by cotreatment with CK666 (SI Appendix, Fig. S10 A and B). These results were further confirmed by small interfering RNA-mediated knockdown of NMIIA and Arp2/3 complex (SI Appendix, Fig. S10 C and D). To further confirm these observations, we used an optogenetic tool that allows timed and local activation of Cdc42 (32), the main regulator of EC protrusions in vivo and in vitro (13). We observed that, in DMSO-treated conditions, Cdc42 activation led to high lamellipodia activity and few filopodia, which was reverted by an inhibitor of Arp2/3 (CK666) (Fig. 4 A and B and Movies S14 and S15). In contrast, BBS treatment abrogated filopodia formation (Fig. 4 A and B and Movie S16). The capacity of forming filopodia in BBS-treated cells was restored by cotreatment with CK666 (Fig. 4 A and B and Movie S17), supporting the hypothesis that NMII activity promotes filopodia formation by limiting the activation of Arp2/3. To verify if NMIIA EC-KO leads to a lack of filopodia and an excess of dactylopodia due to unrestrained Arp2/3 activity in vivo, we generated a double loss of function of both Arp2/3 and NMIIA by crossing NMIIA EC-KO and Arpc4 EC-KO mice. Overall, Arpc4::NMIIA EC double KO mice showed a phenotype very similar to Arpc4 EC-KO, with a strong reduction in radial expansion and compaction at the vascular front (Fig. 4 C and D). Yet abrogation of Arp2/3 rescued filopodia formation in NMIIA-deficient ECs in vivo (Fig. 4 E and F and SI Appendix, Fig. S9B). Altogether, these results demonstrate that NMIIA enables filopodia stability by restricting Arp2/3 activation in endothelial tip cells in vivo.
We next investigated the mechanism by which NMIIA limits Arp2/3 activity. Arp2/3 is activated by WASP/WAVE complexes downstream of the Rho GTPases, Rac1 and Cdc42 (33). A common trigger for Rac1/Cdc42 activation and migration is signaling from immature FAs at the leading edge of cells (33, 34). Our observations showed that Arp2/3-dependent dactylopodia correlated with local invasion into extravascular matrices (Fig. 2F and SI Appendix, Fig. S7), suggesting that integrin-mediated signaling could activate Arp2/3 when engaging with extravascular matrices. In accordance, ITGB1 EC-KO shows striking similarities with Arpc4 EC-KO, including excessive and longer filopodia formation, blunted sprouting front (reminiscent of a lack of dactylopodia), and severely reduced invasion to deeper layers (20). Moreover, it is well established that NMII-dependent activity promotes maturation of integrin adhesions (35). Thus, we hypothesized that Fas could be a platform promoting the cross-talk between NMIIA and Arp2/3 complex at the leading edge of tip cells. To evaluate the state of Fas, we analyzed integrins (ITGA5 and activated ITGB1) and phosphorylated paxillin (pPAX, a marker for more mature FAs). WT tip cells showed high levels of pPAX and activated ITGB1 at the base of filopodia and in dactylopodia but also an enrichment of both ITGA5 and ITGB1 (Fig. 5A and SI Appendix, Fig. S11 A and B). NMIIA-deficient tip cells showed a significant reduction of pPAX, and signals for both ITGA5 and activated ITGB1 were diffused all over dactylopodia when compared to WT tip cells (Fig. 5 A and B and SI Appendix, Fig. S11 A and B). These observations suggest that the inhibition of NMIIA leads to significant differences in integrin location and activation state. Similar results were observed in ECs in vitro. BBS-mediated inhibition of NMII in HUVEC fibroblasts cocultures led to a strong decrease in the number of mature fibrillar Fas and a strong decrease in pPAX, both at immunofluorescence and Western blot level, while CK666 treatment did not modify levels of pPAX (Fig. 5 C and D and SI Appendix, Fig. S12 A–C), which correlates with a decrease in the number of filopodia (SI Appendix, Fig. S10). Our results are suggestive of a mechanism in which immature/nascent adhesions would activate Arp2/3, and NMIIA inhibits this signaling axis by promoting maturation of Fas, as previously reported (35, 36). We next assessed if BBS treatment would promote activation of Rac1, a major positive regulator of Arp2/3 in ECs downstream of integrin signaling. We observed that BBS treatment increased the levels of Rac1-GTP, the active form of Rac1, when compared to DMSO treatment (Fig. 5E). Accordingly, inhibition of Rac1 activation with NSC23766 led to a rescue of filopodia formation in BBS-treated cells (Fig. 5G and SI Appendix, Fig. S13). Tiam1, DOCK180, and Arhgef7/β-PIX were previously implicated in Rac1 activation downstream of integrins (37). In addition, previous work showed that NMIIA inhibits β-PIX recruitment to and activation by FAs (36). Thus, we tested if knockdown of β-PIX could rescue filopodia formation in BBS-treated cells. Indeed, silencing of β-PIX (SI Appendix, Fig. S14A) led to a partial rescue in filopodia number in BBS-treated ECs (Fig. 5 H and I and SI Appendix, Fig. S14B). Taken together, these results suggest that NMIIA balances dactylopodia and filopodia formation by promoting FA maturation and thereby limiting Arp2/3 activation through inhibition of Rac1 activation downstream of integrin β-PIX in nascent adhesions.
Discussion
Deciphering the mechanisms used by ECs to migrate and invade is essential to understand sprouting angiogenesis and to develop novel anti-angiogenic therapies. Altogether, these results demonstrate 1) that Arp2/3 activity is necessary for endothelial tip cell invasiveness and formation of proinvasive dactylopodia; 2) that dactylopodia derive from filopodia; 3) that filopodia are not required for tip cell migration; and 4) that NMIIA enables filopodia stability by restricting Arp2/3 activation in endothelial tip cells in vivo. We found that invasiveness of endothelial tip cells during angiogenesis in vivo depends on the formation of specific Arp2/3-dependent protrusions, the dactylopodia. We found that dactylopodia are derived from filopodia at sites in contact with nonvascular extracellular matrix. Our findings also support the idea that filopodia are not per se sufficient for EC invasion and migration, as previously reported (21). Yet filopodia play a regulatory role as they serve as dactylopodia precursors. Interestingly, our live-imaging analysis showed that only a very small number of filopodia showed membrane-ruffling activity, and WT tip cells present an excess number of filopodia (∼30) over dactylopodia (∼4). Thus, the mechanisms allowing dactylopodia formation must be tightly regulated.
Previous studies have highlighted that Arp2/3 and formins compete with each other to regulate the organization of filamentous actin and to dictate the type of cellular protrusions (38, 39). Remarkably, we show that NMIIA balances the relative proportion of two types of cellular protrusions, favoring filopodia over dactylopodia, a lamellipodia-like structure. This is rather surprising as increased contractility is generally inversely correlated with protrusive activity, as shown in several different models (9, 10). Moreover, we discovered that NMIIA balances the protrusive activity of tip cells by limiting Arp2/3 activation through actomyosin contractility-induced maturation of FAs. Notably, this effect was restricted to NMIIA and not NMIIB, in agreement with reports demonstrating that NMII isoforms have unique roles (23, 25–27). Recently, Ma et al. have also revealed the importance of NMIIA and NMIIB in sprouting angiogenesis during embryonic development (40). While the relative importance of each NMII isoform for a correct development of the vascular network is consistent with our observations, the effects of NMIIA deletion on cortical stability models was not consistent with our in vivo live-imaging results. Instead of an excess of cortical protrusions (filopodia and dactylopodia), we observed a net decrease in the overall number of cortical protrusions. Moreover, no blebbing behavior was observed, in contrast with observations in Ma et al. (40). These differences may be explained by the different models used for live imaging in the two studies, in vitro embryoid body sprouting assays in Ma et al. and our ex vivo assays. This highlights the specific differences and adaptive mechanisms in cell behavior from in vitro and in vivo conditions.
Based on this study and on previous reports, we propose an integrative view on the mechanisms regulating endothelial tip cell’s invasive behavior: VEGFA controls formins, by directly regulating Cdc42 activity (13, 14) and NMIIA, via SRF transcriptional activity (16). This fosters actomyosin contractility and protrusive activity in endothelial tip cells. Cdc42/formin-dependent filopodia activity will engage with extravascular matrices, activating integrin signaling at the base and within filopodia, which promotes Arp2/3 activity downstream of a β-PIX/Rac1 pathway. NMIIA positively regulates the maturation state of FAs, which negatively regulates the β-PIX/Rac1 pathway and thus prevents excessive Arp2/3 activation. Loss of NMIIA activity leads to overactivation of Arp2/3 and unrestrained conversion of filopodia into dactylopodia. Loss of Arp2/3 activity abrogates dactylopodia formation and thus inhibits cell migration and invasion (SI Appendix, Fig. S15). Excessive filopodia formation in Arp2/3-deficient endothelium may be explained by the previously documented competition between actin nucleators (41). Within this model, an outstanding question relates to the mechanism of local control of NMIIA activity that licenses dactylopodium formation. We can speculate that filopodia-dependent signaling (engagement with local guidance cues and extravascular matrix components or cells) would trigger inhibition of NMIIA at the base of filopodia, leading to Arp2/3 activation and dactylopodia formation. Filopodia have been shown to produce pulling forces on the extravascular matrix, a propriety related to NMIIA activity (11), which could be related to dactylopodia formation. Exploration of this molecular cross-talk might provide therapeutic opportunities to sprouting angiogenesis, based on the ability to block invasion of endothelial tip cells.
Methods
Mice and Treatments.
In this study, we used the following mouse strains: Myh9 floxed (42); Myh10 floxed (43); Arpc4 floxed (30); LifeAct-GFP (44); R26mTmG (45); Myh9-GFP (46); and Pdgfb-iCreERT2 (24). Intercrosses between the different mouse strains generated new double and triple transgenic mouse strains. As controls, Cre-negative littermates were used in all experiments. Both males and females were used without distinction. Tamoxifen (Sigma) was injected intraperitoneally (20 µL/g of 1 mg/mL solution) at P1 and P3 before eyes were collected either at P6 and P12 or injected at P4 and P5 and collected at P12, as described previously (47). Additional details about mouse models, as well as all other materials and methods, are described in detail in SI Appendix.
Supplementary Material
Acknowledgments
We thank Clare M. Waterman, Robert Fischer, Robert Adelstein, and Xuefei Ma (National Heart, Lung, and Blood Institute) for discussion and technical support and João Barata, Edgar Gomes (Instituto de Medicina Molecular), and Michael Potente (Max Planck Institute for Heart and Lung Research) for critical review of the manuscript. We thank all members of the Vascular Morphogenesis Laboratory for helpful discussions and critical reading of the manuscript. C.A.F. was supported by a European Research Council starting grant (679368), the European Union H2020-TWINN-2015—Twinning (692322), the Fundação para a Ciência e a Tecnologia funding (grants IF/00412/2012, EXPL/BEX-BCM/2258/2013, PTDC/MED-PAT/31639/2017, and PTDC/BIA-CEL/32180/2017 and fellowships CEECIND/04251/2017 and CEECIND/02589/2018), and a grant from the Fondation Leducq (17CVD03).
Footnotes
The authors declare no competing interest.
This article is a PNAS Direct Submission.
This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2023829118/-/DCSupplemental.
Data Availability
All study data are included in the article and/or supporting information.
References
- 1.Augustin H. G., Koh G. Y., Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology. Science 357, eaal2379 (2017). [DOI] [PubMed] [Google Scholar]
- 2.Potente M., Mäkinen T., Vascular heterogeneity and specialization in development and disease. Nat. Rev. Mol. Cell Biol. 18, 477–494 (2017). [DOI] [PubMed] [Google Scholar]
- 3.Gerhardt H., et al., VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161, 1163–1177 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Jacquemet G., Hamidi H., Ivaska J., Filopodia in cell adhesion, 3D migration and cancer cell invasion. Curr. Opin. Cell Biol. 36, 23–31 (2015). Correction in: Curr. Opin. Cell Biol. 37, 119 (2015). [DOI] [PubMed] [Google Scholar]
- 5.Pollard T. D., Actin and actin-binding proteins. Cold Spring Harb. Perspect. Biol. 8, a018226 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Rottner K., Schaks M., Assembling actin filaments for protrusion. Curr. Opin. Cell Biol. 56, 53–63 (2019). [DOI] [PubMed] [Google Scholar]
- 7.Yamada K. M., Sixt M., Mechanisms of 3D cell migration. Nat. Rev. Mol. Cell Biol. 20, 738–752 (2019). [DOI] [PubMed] [Google Scholar]
- 8.Mattila P. K., Lappalainen P., Filopodia: Molecular architecture and cellular functions. Nat. Rev. Mol. Cell Biol. 9, 446–454 (2008). [DOI] [PubMed] [Google Scholar]
- 9.Elliott H., et al., Myosin II controls cellular branching morphogenesis and migration in three dimensions by minimizing cell-surface curvature. Nat. Cell Biol. 17, 137–147 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Fischer R. S., Gardel M., Ma X., Adelstein R. S., Waterman C. M., Local cortical tension by myosin II guides 3D endothelial cell branching. Curr. Biol. 19, 260–265 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Alieva N. O., et al., Myosin IIA and formin dependent mechanosensitivity of filopodia adhesion. Nat. Commun. 10, 3593 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Fonseca C. G., Barbacena P., Franco C. A., Endothelial cells on the move: Dynamics in vascular morphogenesis and disease. Vasc. Biol. 2, H29–H43 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Laviña B., et al., Defective endothelial cell migration in the absence of Cdc42 leads to capillary-venous malformations. Development 145, dev161182 (2018). [DOI] [PubMed] [Google Scholar]
- 14.Fantin A., et al., NRP1 regulates CDC42 activation to promote filopodia formation in endothelial tip cells. Cell Rep. 11, 1577–1590 (2015). Correction in: Cell Rep.13, 2037 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Nohata N., et al., Temporal-specific roles of Rac1 during vascular development and retinal angiogenesis. Dev. Biol. 411, 183–194 (2016). [DOI] [PubMed] [Google Scholar]
- 16.Franco C. A., et al., SRF selectively controls tip cell invasive behavior in angiogenesis. Development 140, 2321–2333 (2013). [DOI] [PubMed] [Google Scholar]
- 17.Weinl C., et al., Endothelial SRF/MRTF ablation causes vascular disease phenotypes in murine retinae. J. Clin. Invest. 123, 2193–2206 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Franco C. A., et al., Serum response factor is required for sprouting angiogenesis and vascular integrity. Dev. Cell 15, 448–461 (2008). [DOI] [PubMed] [Google Scholar]
- 19.Park H., et al., Integrin-linked kinase controls retinal angiogenesis and is linked to Wnt signaling and exudative vitreoretinopathy. Nat. Commun. 10, 5243 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Yamamoto H., et al., Integrin β1 controls VE-cadherin localization and blood vessel stability. Nat. Commun. 6, 6429 (2015). [DOI] [PubMed] [Google Scholar]
- 21.Phng L.-K., Stanchi F., Gerhardt H., Filopodia are dispensable for endothelial tip cell guidance. Development 140, 4031–4040 (2013). [DOI] [PubMed] [Google Scholar]
- 22.Vanlandewijck M., et al., A molecular atlas of cell types and zonation in the brain vasculature. Nature 554, 475–480 (2018). Correction in: Nature560, E3 (2018). [DOI] [PubMed] [Google Scholar]
- 23.Wang A., et al., Nonmuscle myosin II isoform and domain specificity during early mouse development. Proc. Natl. Acad. Sci. U.S.A. 107, 14645–14650 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Claxton S., et al., Efficient, inducible Cre-recombinase activation in vascular endothelium. Genesis 46, 74–80 (2008). [DOI] [PubMed] [Google Scholar]
- 25.Even-Ram S., et al., Myosin IIA regulates cell motility and actomyosin-microtubule crosstalk. Nat. Cell Biol. 9, 299–309 (2007). Correction in: Nat. Cell Biol.9, 480 (2007). [DOI] [PubMed] [Google Scholar]
- 26.Sandquist J. C., Means A. R., The C-terminal tail region of nonmuscle myosin II directs isoform-specific distribution in migrating cells. Mol. Biol. Cell 19, 5156–5167 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Vicente-Manzanares M., Koach M. A., Whitmore L., Lamers M. L., Horwitz A. F., Segregation and activation of myosin IIB creates a rear in migrating cells. J. Cell Biol. 183, 543–554 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Sawamiphak S., Ritter M., Acker-Palmer A., Preparation of retinal explant cultures to study ex vivo tip endothelial cell responses. Nat. Protoc. 5, 1659–1665 (2010). [DOI] [PubMed] [Google Scholar]
- 29.Prahst C., et al., Mouse retinal cell behaviour in space and time using light sheet fluorescence microscopy. eLife 9, e49779 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Krndija D., et al., Active cell migration is critical for steady-state epithelial turnover in the gut. Science 365, 705–710 (2019). [DOI] [PubMed] [Google Scholar]
- 31.Bishop E. T., et al., An in vitro model of angiogenesis: Basic features. Angiogenesis 3, 335–344 (1999). [DOI] [PubMed] [Google Scholar]
- 32.Guntas G., et al., Engineering an improved light-induced dimer (iLID) for controlling the localization and activity of signaling proteins. Proc. Natl. Acad. Sci. U.S.A. 112, 112–117 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hodge R. G., Ridley A. J., Regulating Rho GTPases and their regulators. Nat. Rev. Mol. Cell Biol. 17, 496–510 (2016). [DOI] [PubMed] [Google Scholar]
- 34.Etienne-Manneville S., Hall A., Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta. Cell 106, 489–498 (2001). [DOI] [PubMed] [Google Scholar]
- 35.Chrzanowska-Wodnicka M., Burridge K., Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J. Cell Biol. 133, 1403–1415 (1996). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kuo J.-C., Han X., Hsiao C.-T., Yates J. R. III, Waterman C. M., Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation. Nat. Cell Biol. 13, 383–393 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Huveneers S., Danen E. H. J., Adhesion signaling–Crosstalk between integrins, Src and Rho. J. Cell Sci. 122, 1059–1069 (2009). [DOI] [PubMed] [Google Scholar]
- 38.Rotty J. D., et al., Profilin-1 serves as a gatekeeper for actin assembly by Arp2/3-dependent and -independent pathways. Dev. Cell 32, 54–67 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Suarez C., et al., Profilin regulates F-actin network homeostasis by favoring formin over Arp2/3 complex. Dev. Cell 32, 43–53 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ma X., et al., Nonmuscle myosin 2 regulates cortical stability during sprouting angiogenesis. Mol. Biol. Cell 31, 1974–1987 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Carlier M.-F., Shekhar S., Global treadmilling coordinates actin turnover and controls the size of actin networks. Nat. Rev. Mol. Cell Biol. 18, 389–401 (2017). [DOI] [PubMed] [Google Scholar]
- 42.Léon C., et al., Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. Blood 110, 3183–3191 (2007). [DOI] [PubMed] [Google Scholar]
- 43.Tullio A. N., et al., Nonmuscle myosin II-B is required for normal development of the mouse heart. Proc. Natl. Acad. Sci. U.S.A. 94, 12407–12412 (1997). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Riedl J., et al., Lifeact mice for studying F-actin dynamics. Nat. Methods 7, 168–169 (2010). [DOI] [PubMed] [Google Scholar]
- 45.Muzumdar M. D., Tasic B., Miyamichi K., Li L., Luo L., A global double-fluorescent Cre reporter mouse. Genesis 45, 593–605 (2007). [DOI] [PubMed] [Google Scholar]
- 46.Zhang Y., et al., Mouse models of MYH9-related disease: Mutations in nonmuscle myosin II-A. Blood 119, 238–250 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Franco C. A., et al., Non-canonical Wnt signalling modulates the endothelial shear stress flow sensor in vascular remodelling. eLife 5, e07727 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All study data are included in the article and/or supporting information.